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Different studies have shown the high prevalence of emotional 
diffi culties in cancer survivors. Anxiety and depression are the 
most frequent problems (Kuhnt et al., 2016), with a prevalence 
of 17.9% and 11.6% respectively, both superior to those found in 
healthy control groups (Mitchell, Ferguson, Gill, Paul, & Symonds, 
2013). In order to understand this high prevalence, it is important 
to bear in mind the implications of cancer.  
The disease and diagnosis mark the beginning of a process which 
will involve many adverse experiences. The disease, the tests and 
medical treatments frequently include unpleasant and impeding 
experiences such as pain and fatigue. Furthermore, the disease 
requires frequent visits to the hospital for check-ups and treatment. 
These experiences and conditions frequently lead to patients reducing 
their involvement in relevant and/or pleasant activities. In some 
cases, health workers and those close to the patient also encourage 
this reduction in involvement, or even abandonment of activities, as a 
means to enabling the patient to better care for his/her health.
The abandonment of tasks and responsibilities may produce 
relief in the short term. However, distancing oneself from day-to-
day activities reduces the chances of maintaining contact with the 
rewarding situations and valuable conditions of life. In particular, 
changes in relationships with friends and in leisure have been 
related to a depressed state of mind, lower quality of life, tiredness, 
insomnia and pain. When treatment fi nishes, although a gradual 
recovery of the majority of day-to-day activities is observed, 
this is always smaller amongst patients with a greater degree of 
depression (Cataldo & Brodsky, 2013).
Having fi nished their oncological treatment, patients frequently 
suffer from physical complaints and tiredness, attention and 
concentration diffi culties and have to adapt to living with physical 
changes. These after-effects, some permanent, can interfere with 
the maintenance or recovery of roles important to them (Fernández 
et al., 2011).
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Abstract Resumen
Background: Behavioral activation (BA) and acceptance and commitment 
therapy (ACT) are considered particularly useful treatments when dealing 
with emotional problems of cancer survivors. The effi cacy of these two 
treatments, applied on a group basis, were evaluated and compared. 
Method: An analysis was carried out of pre-post treatment changes in the 
emotional state and patterns of activation/avoidance of 52 cancer patients, 
with anxiety and/or depression, randomly assigned to three groups (BA/
ACT/waiting list control). Results: Both therapies were superior to no 
treatment in all the variables evaluated. Signifi cant differences were 
found between the two treatments in favor of ACT in social impairment 
and avoidance/rumination. Conclusions: BA and ACT, applied on a 
group basis, are effi cacious in the treatment of those emotional diffi culties 
most prevalent in cancer survivors. Results suggest that activation and 
avoidance are the mechanisms responsible for the changes.
Keywords: Randomized controlled trial, depression, anxiety, 
psychotherapy.
Tratamiento de ansiedad y depresión en supervivientes de cáncer: 
activación conductual versus terapia de aceptación. Antecedentes: 
la activación conductual (AC) y la terapia de aceptación y compromiso 
(ACT) se plantean como tratamientos especialmente útiles para los 
problemas emocionales de los supervivientes de cáncer. Se evaluó y 
comparó la efi cacia de ambas terapias aplicadas en formato grupal. 
Método: se analizaron los cambios pre-post tratamiento en el estado 
emocional y los patrones de activación/evitación de 52 supervivientes de 
cáncer con ansiedad y/o depresión que se asignaron aleatoriamente a tres 
grupos (AC/ACT/control de lista de espera). Resultados: ambas terapias 
fueron superiores al no tratamiento en todas las variables evaluadas. Se 
encontraron diferencias signifi cativas entre tratamientos a favor de la ACT 
en deterioro social y evitación/rumia. Conclusiones: la AC y la ACT, 
en formato grupal, son efi caces para el tratamiento de las difi cultades 
emocionales más prevalentes en supervivientes de cáncer. Los resultados 
apuntan a la activación y la evitación como mecanismos responsables de 
los cambios. 
Palabras clave: ensayo controlado aleatorizado, depresión, ansiedad, 
psicoterapia.
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When faced with these problems and limitations, together with 
the experience of receiving the diagnosis and treatment of cancer, 
patients frequently experience unpleasant thoughts, feelings and 
memories. A common reaction to these experiences, encouraged and 
reinforced by the cultural context, is to try to avoid them. However, 
attempting to control thoughts and unpleasant emotions is associated 
with emotional problems (Berrocal, Rivas, Venditti, & Bernini, 
2016; Nieto & Barraca, 2017). These attempts not only do not 
achieve the desired relief but generate more discomfort, contribute 
to perpetuating it, and limit involvement in important areas of life. 
Consequently, behavioral inhibition, which reduces opportunities to 
maintain contact with the rewarding and valuable situations of life, 
together with the increase in adverse experiences related to the disease 
and its treatment and the strategy of avoiding such experiences may 
be related to the emotional problems of oncological patients.
Psychological intervention, particularly cognitive behavioral 
therapy, has been shown to achieve positive results in the 
treatment of oncological patients. However, its effectiveness has 
only been proven with regard to short term benefi ts in specifi c 
areas. The majority of studies have used supportive expressive or 
cognitive behavioral therapy approaches. This fact may have been 
responsible for the limited results. It is believed that interventions 
that are holistic and context-based, as in the case of the third-
generation therapies, rather than symptom-based, may achieve 
better results since they adapt better to the needs of oncological 
patients (Hulbert-Williams, Storey, & Wilson, 2015). 
Of the third-generation therapies, behavioral activation (BA) and 
acceptance and commitment therapy (ACT), due to the emphasis 
they place on eliminating avoidance and encouraging activation 
(Hulbert-Williams et al., 2015; Kanter, Baruch, & Gaynor, 2006), 
may be particularly useful in the treatment of emotional diffi culties 
in cancer survivors. The goals of these therapies comply with the 
previously described situation, characterized by the avoidance of 
unpleasant private events related to the disease and a reduction in 
involvement in relevant activities. 
Both therapies have shown good results in the psychological 
treatment of cancer survivors. BA has been shown to be useful both in 
the prevention and treatment of emotional problems in studies which 
were rigorous in terms of their methodology (González, Fernández, 
Padierna, Besteiro, & Pérez, in press). Similarly, all the studies using 
ACT, despite the heterogeneity of the experiment designs, show 
improvements in the emotional state and quality of life of the participants 
(e.g., Rost, Wilson, Buchanan, Hildebrant, & Mutch, 2012). 
The aim of the present study is to analyze the effi cacy of BA 
and ACT, applied on a group basis, in the treatment of emotional 
diffi culties in cancer survivors. The importance of carrying 
out such a study lies, fi rstly, in the fact that only ACT has been 
studied in cancer survivors on a group basis, and only in a limited 
number of studies, and secondly, as far as we are aware, it has 
never been compared to BA. The fi rst aspect is important with 
regard to improving the effi ciency of the psychological treatments. 
The second is particularly relevant with regard to the objective of 
identifying responsible factors for the clinical change. 
Method
Participants
The sample was composed of 52 subjects of between 34 and 
62 years of age (M=51.66; SD=6.76). The 92.3% were women and 
7.7% men, 88.2% had received a diagnosis of breast cancer and 
11.8% had been diagnosed with other types of cancer. The inclusion 
criteria for the study were to be between 18 and 65 years of age, to 
have fi nished oncological treatment with surgery, chemotherapy 
and/or radiotherapy for any type of malignant tumor, to currently 
be free of any type of oncological disease and to suffer clinically 
signifi cant emotional distress (score≥8 in at least one of the subscales 
of the Hospital Anxiety and Depression Scale). The exclusion 
criteria were to be receiving another type of psychological therapy, 
to suffer physical deterioration which might hinder participation 
in the therapy, cognitive deterioration and when participation in 
group therapy was not considered to be appropriate.  
Instruments
Hospital Anxiety and Depression Scale (HADS; Zigmond & 
Snaith, 1983) is a 14-item scale with 2 subscales, Anxiety and 
Depression. The total HADS score ranges from 0 to 42 while the 
subscales range from 0 to 21. In depression and anxiety subscales, 
scores of 8-10 indicate probable and scores over 10 indicate 
clinical cases. In psycho-oncology, the HADS score has been 
proven to be an accurate instrument in identifying cancer patients 
with depression (Katz, Kopek, Waldron, Devins, & Tomlinson, 
2004) and anxiety (Walker et al., 2007). 
Environmental Reward Observation Scale (EROS; Armento 
& Hopko, 2007). A self-administered questionnaire which 
supplies information regarding the quantity and availability of 
reinforcement received from the patient’s environment. It consists 
of 10 items, answered using a 4-option Likert scale. Higher scores 
indicate a greater quantity and availability of reinforcement. The 
Spanish adaptation was used (Barraca & Pérez-Álvarez, 2010) 
whose reliability and validity has been shown.
Acceptance and Action Questionnaire-II (AAQ-II; Bond 
et al., 2011). This is a self-rating questionnaire designed to 
measure experiential avoidance and psychological infl exibility. It 
consists of 7 items, answered using a 7-point Likert scale. High 
scores indicate a greater degree of experiential avoidance and 
psychological infl exibility. The Spanish translation showed good 
internal consistency and scores showed signifi cant relationships 
with general scales measuring psychopathological state and 
quality of life (Ruiz, Langer, Luciano, Cangas, & Beltrán, 2013).
Behavioral Activation for Depression Scale (BADS; Kanter, 
Mulick, Busch, Berlin, & Martell, 2007). Consists of 25 items 
measuring four dimensions: Activation, Avoidance/Rumination, 
Work/School Impairment and Social Impairment. A 7-point Likert 
scale is used. The scale provides scores for each of the dimensions 
and also a total score. High scores in Activation and in the total 
score show a higher level of activation, whilst higher scores in 
the other dimensions indicate a greater degree of impairment. 
The Spanish adaptation (Barraca, Pérez-Álvarez, & Lozano, 2011) 
proved to be valid and had internal consistency. Factor analysis 
confi rmed the four dimensions of the original instrument.
Procedure
In order to obtain participants for the study, Primary Care 
and Oncology healthcare professionals, associations of cancer 
patients and the general population were informed about the 
study. Those people who contacted the research team interested in 
participating in the study were assessed using a clinical interview 
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and standardized self-report instruments. All participants signed 
a written consent. 
Those participants who fulfi lled the inclusion criteria were 
assigned at random to two experimental groups and a waiting list 
control group. The people assigned to the experimental groups 
participated in one of the therapies being studied (BA/ACT), which 
were applied on a group basis (maximum 6 people) over 12 weekly 
sessions of 90 minutes. The interventions were led by two clinical 
psychologists, each with relevant training and experience in both 
of the therapies being studied. Supervision sessions were held 
in order to ensure adhesion to therapeutic protocols. Following 
completion of the intervention, the evaluation instruments were 
again applied to all participants. Details of the study process are 
shown in Figure 1. 
Both therapies were applied following protocols designed ad 
hoc for the study. These protocols were based on reference manuals 
for each of the therapies (Hayes, Strosahl, & Wilson, 2014; Hopko 
& Lejuez, 2007; Martell, Dimidjian, & Herman-Dunn, 2013). The 
sessions were structured as follows: review of work done between 
sessions, work on those aspects programmed for the session, 
planning of work for the following week. The objectives and 
procedures of each of the interventions are described below. 
Assessment
N = 98
Fulfilled criteria
N = 71
Did not fulfil criteria
N = 27
- Not able to attend therapy (n = 4)
- Rejected therapy due to format (n = 1)
Randomization
N = 66
CG
Pre n = 27
BA
Pre n = 22
ACT
Pre n = 17
- Abandoned (n = 3)
- Couldn’t be
contacted (n = 1)
- Abandoned (n = 2)
- Did not comply to
therapy norms (n = 2)
- Cancer relapse (n = 1)
- Did not comply to
therapy norms (n = 1)
- Cancer relapse (n = 1)
- Change in circumstances making
attendance difficult (n = 2)
- Did not complete assessment
instruments in post (n = 1)
Post n = 17Post n = 23 Post n = 12
Figure 1. Study fl ow diagram
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The BA was aimed at reestablishing relevant day-to-day 
routines and activities, increasing rewarding activities, eliminating 
illness behavior and modifying patterns of experiential avoidance. 
The targets and tasks for each case and in each session of the 
intervention were determined using functional behavioral 
analysis. This allowed participants to learn to observe the 
relationship between what they did, felt and thought and what 
happened around them. The principal techniques employed were 
self-observation and self-report, rehearsal and behavior modeling, 
elaboration of activity hierarchies, behavior programming, 
contingency management and use of metaphors and experiential 
exercises to facilitate acceptance of and distancing from emotions 
and thoughts. When necessary, problem solving and training in 
social skills was also used.
The objective of the ACT was to invert all the processes 
involved in psychological infl exibility. In the fi rst sessions, the 
main topics dealt with were experiential avoidance, infl exible 
attention, attachment to the conceptualized self and cognitive 
fusion. As from the eighth session, work focused mainly on the 
connection with values and commitment to rewarding actions. The 
techniques used most widely throughout the therapy to achieve 
the different objectives were metaphors and experiential exercises. 
With a view to promoting commitment to rewarding experiences, 
the following techniques were used: rehearsal and behavior 
modeling, behavioral programming, contingency management 
and, when necessary, training in how to act in order to achieve 
relevant objectives.
The study was conducted in accordance with codes of ethics 
and conduct specifi ed by the American Psychologist Association 
and was approved by the Research Ethics Committee of the 
Principality of Asturias, Spain (Ref. 45/14).
Data analysis
In order to compare groups regarding sociodemographic and 
disease-related variables, the chi-square test was used for the 
categorical variables (sex, marital status, profession, work situation, 
level of studies, location of the tumor, oncological treatment 
received) and the Kruskal-Wallis test for quantitative variables 
with important asymmetry (age, number of children, number of 
people in the household). The equivalence between the groups for 
the pre-measures of all the dependent variables was tested using 
one-way ANOVAs, followed by a Scheffé test (or Dunnett’s T3 in 
the case of heteroscedasticity) for post-hoc comparisons.
In order to compare pre- and post-treatment measures, 
repeated-measures ANOVAs were used, taking the group as 
the inter-factor. In the case of instruments made up of various 
subscales, repeated-measures multivariate analyses were carried 
out previously (Wilks’ lambda) taking the subscales as different 
dependent variables. In order to carry out the ANOVAs, it was fi rst 
confi rmed that all the dependent variables had normal (Shapiro-
Wilk’s test) or approximately normal distribution (asymmetry and 
kurtosis indexes less than 1). The effect size was quantifi ed by 
partial eta2.
Results 
Before starting the treatment, there were no differences between 
the groups with regard to sociodemographic and disease-related 
variables. In the pre-treatment measures of the dependent variables, 
signifi cant differences were found between the groups in the AAQ-
II (F2,48=5.03, p=.010) and in the Work/School Impairment 
subscale of the BADS (F2,49=4.83, p=.012). In both cases, the 
scores of the ACT group were signifi cantly higher than those of the 
control group. The levels of signifi cance were p=.020 in the Work/
School Impairment subscale and p=.012 in the AAQ-II. 
The mean scores of the groups in the pre- and post-treatment 
measures of the dependent variables are shown in Table 1. All 
variables had normal or approximately normal distribution.
The results of the univariate and multivariate analyses to 
compare the pre- and post-measures of the groups are shown 
below. In all the analyses, the multivariate homoscedasticity (Box’s 
M) and the normal distribution of the residues were tested. The 
fi rst criterion was not fulfi lled in the HADS, AAQ-II and EROS. 
The distribution of the standardized residues conformed to the 
Table 1
Means and standard deviations of the groups
Pre
M(SD)
Post
M(SD)
HADS-A
CG
BA
ACT
11.57(2.66)
12(3.32)
13.33(2.90)
10.04(2.29)
6.59(3.59)
7.50(3.87)
HADS-D
CG
BA
ACT
7.74(4.57)
8(2.18)
9.83(4.51)
7.65(3.83)
4.29(3.24)
5.58(3.45)
EROS
CG
BA
ACT
25.30(5.91)
24.76(5.12)
21.58(2.94)
25.52(6.58)
31.53(5.12)
28.67(5.19)
AAQ-II
CG
BA
ACT
27.36(8.87)
32(6.83)
36.08(7.06)
27.36(11.21)
22.59(8.46) 
24.33(10.39)
BADS-A
CG
BA
ACT
20.19(8.09)
19.35(8.17)
19.67(10.27)
20.23(9.85)
28.32(7.44)
25.97(10.94)
BADS-WSI
CG
BA
ACT
10.17(7.74)
15.12(7.46)
17.83(6.38)
11.45(6.62)
8.24(8.02)
8.50(6.04)
BADS-SI
CG
BA
ACT
8.87(8.32)
8.59(7.52)
15.67(9.59)
8.45(7.78)
5.24(5.97)
5.25(6.14)
BADS-A/R
CG
BA
ACT
23.30(8.80)
25(7.83)
30(10.31)
21.32(9.99)
17.71(11.68)
13(8.79)
Note: CG: Control Group. BA: Behavioral Activation. ACT: Acceptance and Commitment 
Therapy. Pre: Pretreatment. Post: Posttreatment. HADS-A: Anxiety subscale of HADS. 
HADS-D: Depression subscale of HADS. EROS: Environmental Reward Observation 
Scale. AAQ-II: Acceptance and Action Questionnaire–II. Dimensions BADS: A: 
Activation. WSI: Work/School Impairment. SI: Social Impairment. A/R: Avoidance/
Rumination
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normal curve in all variables except the Work/School Impairment 
subscale of the BADS (K-S test).
HADS. The intra-factor effect was signifi cant when the two 
scales were considered jointly (F2,48=47.25, p<.001, η
p
2=.663) as 
was its interaction with the group (F4,98=5.33, p=.001, η
p
2=.182). 
When each scale was considered separately, interaction with the 
group was signifi cant, both in Anxiety (F2,49= 11.62, p<.001, 
η
p
2=.322) and Depression scales (F2,49=.98, p=.005, η
p
2=.196). 
In both cases, the differences between pre- and post-measures 
were signifi cantly larger for the experimental groups than for the 
control group. There were no differences between the slopes of the 
experimental groups. 
EROS. The effect of the intra-factor was signifi cant 
(F1,48=29.09, p<.001, η
p
2=.377) as was its interaction with the 
group (F2,48=7.16, p=.002, η
p
2=.230). The increase in the scores 
from the pre- to the post- only occurred in the experimental groups 
and to a similar degree in both.
AAQ-II. The interaction between the intra-factor and the group 
was signifi cant (F2,48=8.21, p=.001; η
p
2=.255). There were no 
pre-post differences in the control group whilst a similar decrease 
was observed in the two experimental groups.
BADS. Pre-post differences were only observed in the 
experimental groups. When the four scales were considered jointly, 
the multivariate contrasts for the intra-factor and its interaction 
with the group were signifi cant (F8,92=3.56, p=.001; η
p
2=.24). 
When each scale was considered separately, interaction of the intra-
factor with the group was signifi cant in Activation (F2,48=4.065, 
p=.002; η
p
2=.145), Work/School Impairment (F2,48=8.85, p=.001; 
η
p
2=.269), Social Impairment (F2,48=6.70, p=.003; η
p
2=.218) and 
Avoidance/Rumination (F2,48=7.135, p=.002; η
p
2=.229). When 
the two experimental groups were compared with each other, there 
was signifi cant interaction with the intra-factor in the variables of 
Social Impairment (F1,27=5.38, p=.028; η
p
2=.166) and Avoidance/
Rumination (F1,27=4.14, p=.050). In both cases, the pre-post 
decrease was signifi cantly larger in the ACT group. 
Discussion 
The objective of this study was to analyse the effi cacy of BA 
and ACT, applied on a group basis, in the treatment of emotional 
diffi culties in cancer survivors. The design of the study, the 
psychometric guarantees of the evaluation instruments and 
safeguards of the statistical tests used guarantee the validity of 
the results obtained. 
The sample consisted of survivors of different types of cancer. 
However, the fact that the participants had received different 
oncological diagnoses and different treatments certainly does not 
mean that the results cannot be generalized. It must be remembered 
that, as survivors, they all shared the same clinical condition, that 
is, they were all free of oncological disease at the time of the study. 
Furthermore, their emotional distress was potentially related to 
the same condition, that of having received a diagnosis of, and 
treatment for, cancer. Samples of patients with different types of 
cancer are common in other studies investigating the effi cacy of 
the same therapies studied here (Arch & Mitchell, 2016; Hopko 
et al., 2008). It is true that the fact that a high percentage of the 
sample had suffered from breast cancer meant a higher presence 
of women in the study and this fact may have had an infl uence 
on the emotional state of the sample. It is known that emotional 
disorders are more prevalent amongst women and also that 
women are more willing than men to seek professional help for 
such disorders (Steel et al., 2014). Although this, together with 
the high prevalence of breast cancer, would explain the unequal 
composition of the sample in terms of gender, this condition must 
be taken into account when generalizing the results. 
In general, the participants showed more anxiety than 
depression in the pre-treatment. This result coincides with those 
of numerous studies, which show a greater prevalence of anxiety 
than depression in cancer survivors (Mitchell et al., 2013). 
In the pre-treatment, differences were found between the ACT 
group and the control group in the AAQ-II and in the Work/
School Impairment subscale of the BADS. Despite the fact that 
the participants in the ACT group showed a higher degree of 
experiential avoidance and greater work/school impairment, 
no differences were found between the groups in the measures 
of emotional distress in the pre-treatment. Consequently, the 
initial differences do not affect the value of the results obtained 
regarding the post-treatment emotional changes observed. It is, 
however, important to bear in mind the differences in the pattern 
of psychological infl exibility when evaluating the results, fi rstly 
as a mediator in the emotional distress of the participants in 
the study and, secondly, as a modulator of the effects of each of 
the interventions. On this point, it should be remembered that 
both interventions aim to modify the pattern of psychological 
infl exibility, although each uses different strategies. 
The AC and the ACT were superior to no treatment in all the 
variables studied. The subjects who participated in the therapies 
showed a reduction in anxiety and depression (HADS), an increase 
in activation (EROS, BADS: Activation, Work/School Impairment, 
Social Impairment) and a reduction in avoidance (AAQ-II; 
BADS: Avoidance/Rumination). These results demonstrate that 
the therapies provoked the desired changes. The fact that both 
therapies, aimed at increasing activation and reducing avoidance, 
achieved improvements, not only in these patterns but also in the 
emotional distress of the participants, supports the idea that both 
patterns play a key role in the onset, maintenance and treatment 
of emotional problems in this population. Previous studies of BA 
(Fernández et al., in press; 2011) and of ACT (Arch & Mitchell, 
2016; Rost et al., 2012) found similar changes when treating 
oncological patients, reporting changes in activation and avoidance 
as well as an improvement in emotional state and quality of life. 
Regarding the comparison between the experimental groups, 
signifi cant differences were found in favour of ACT in the Social 
Impairment and Avoidance/Rumination variables (BADS). 
According to these results, ACT appears to be more effi cacious 
than BA. However, it is important to bear in mind that, although the 
differences were not statistically signifi cant, in the pre-treatment 
the participants in the ACT group showed greater affectation than 
the participants in the BA group in both aspects. What is more, 
the ACT group showed greater Work/School Impairment (BADS) 
and greater avoidance (AAQ-II) than the control group in the 
pre-treatment. In this case the differences were signifi cant. The 
fact that the participants in the ACT group were worse in the pre-
treatment could have facilitated their improvement. In a previous 
study in which BA was applied (Fernández et al., in press; 2011), 
those people with greater emotional diffi culties also benefi ted more 
from the treatment. Furthermore, studies typically show that the 
patients that improve most are those with a clinically diagnosable 
disorder rather than those with more generic distress. In the other 
variables, the two therapies proved to be equally effi cacious.  
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Both therapies had the same objectives: to reduce infl exible 
avoidance of thoughts, feeling and memories related to the 
oncological process and to encourage involvement in rewarding 
activities, each therapy following a different procedure. In the BA, 
the recuperation of rewarding activities implies abandoning of 
avoidance behaviour. Consequently, an integrated approach was 
taken throughout the therapy when working on the two conditions. 
The intervention related to avoidance and activation was always 
determined by a functional analysis of the participants’ diffi culties. 
However, the ACT focused primarily on reducing experiential 
avoidance and most of the therapy time was dedicated to this 
objective. Only later in the therapy was attention paid to activation 
and commitment in line with the subject’s values. Furthermore, in 
the ACT, functional analysis did not play as important a role as it 
did in the BA. 
The two therapies studied were both superior to no treatment. 
This appears to indicate that the effi cacy of the treatment depends, 
not so much on how avoidance and activation is treated, but rather 
on the ability of the therapy used to provoke a signifi cant change 
in the two conditions. In light of the differences found between 
the experimental groups, the question arises as to whether ACT is 
more effi cacious than BA in the treatment of cancer survivors with 
emotional problems in general, or, more specifi cally, in those whose 
main problem is anxiety. In the study carried out by González-
Fernández et al. (2017), avoidance was related both to anxiety and 
depression whilst low degrees of activation were associated more 
specifi cally with depression. The participants in this study showed 
a greater presence of anxiety than of depression. It is, therefore, 
possible that the greater effi cacy of ACT was related to the greater 
emphasis of this therapy on reducing avoidance. Similarly, BA 
may be more effi cacious than ACT in the treatment of survivors 
with depression. 
Despite the value of the results of the present study, we believe 
it is necessary to analyse the relative effi cacy of the two therapies 
in greater depth. To do so, it may be useful to include the following: 
follow-up data, assessment using other procedures, standardized 
self-report instruments, studies involving larger samples and an 
analysis of the specifi c diffi culties of the patients involved in 
each of the therapies. Furthermore, randomized controlled trials 
comparing the effi cacy of the therapies with psychological-
placebo interventions and with other effi cacious therapies would 
be of particular interest.
The results of this study show, fi rstly, the effi cacy of BA and 
ACT, applied on a group basis, in the treatment of the most prevalent 
emotional problems in cancer survivors and, secondly, the key role 
played by avoidance and activation in the onset, maintenance and 
treatment of these problems. We believe these results to be important 
due to their relevance for clinical practice. They can contribute 
to a more effi cient application of psychological treatments and 
also provide a greater insight into the active principles of those 
treatments. This latter aspect is of fundamental importance, since 
a knowledge of these principals is what, ultimately, will make it 
possible to progress in the implementation of treatments which 
adapt to and resolve the emotional problems of each individual. 
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